Dasatinib in KIT D816V-Mutation of a metastatic Melanoma

被引：0
|
作者：
Schulze, F. [1 ]
Anguen, O. [1 ]
Zillikens, D. [1 ]
Terheyden, P. [1 ]
机构：
[1] Univ Lubeck, Klin Dermatol Allergol & Venerol, Lubeck, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2010年 / 8卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：762 / 762
页数：1
相关论文
共 50 条
  • [41] Distinct signalling pathways for mutated KIT(V560G) and KIT(D816V) in mastocytosis
    Chan, I. J.
    Kasprowicz, S.
    Tharp, M. D.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2013, 38 (05) : 538 - 544
  • [42] PKC412, inhibitor of the KIT tyrosine kinase, demonstrates efficacy in mast cell leukemia with the D816V KIT mutation.
    Gotlib, J
    Berube, C
    Ruan, J
    Growney, J
    Dugan, K
    Falkow, R
    Rosamilia, M
    Resta, D
    Cohen, P
    Fabbro, D
    Heinrich, M
    Gilliland, DG
    Coutre, S
    BLOOD, 2003, 102 (11) : 919A - 919A
  • [43] KIT/D816V induces SRC-mediated tyrosine phosphorylation of MITF and altered transcription program in melanoma
    Phung, Bengt
    Kazi, Julhash U.
    Lundby, Alicia
    Bergsteinsdottir, Kristin
    Sun, Jianmin
    Goding, Colin R.
    Jonsson, Gdran
    Olsen, Jesper V.
    Steingrimsson, Eidkur
    Ronnstrand, Lars
    CANCER RESEARCH, 2016, 76
  • [44] An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis
    C Teodosio
    A C García-Montero
    M Jara-Acevedo
    I Álvarez-Twose
    L Sánchez-Muñoz
    J Almeida
    J M Morgado
    A Matito
    L Escribano
    A Orfao
    Leukemia, 2012, 26 : 951 - 958
  • [45] An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis
    Teodosio, C.
    Garcia-Montero, A. C.
    Jara-Acevedo, M.
    Alvarez-Twose, I.
    Sanchez-Munoz, L.
    Almeida, J.
    Morgado, J. M.
    Matito, A.
    Escribano, L.
    Orfao, A.
    LEUKEMIA, 2012, 26 (05) : 951 - 958
  • [46] Proof of clinical activity of Dasatinib in a patient with mutant-KIT D816V positive core binding factor leukemia (CBF AML)
    Schittenhelm, M.
    Bonzheim, I
    Witte, K.
    Soekler, M.
    Kanz, L.
    Kampa-Schittenhelm, K.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 47 - 47
  • [47] DIGITAL PCR IS A PROMISING METHOD FOR SENSITIVE DETECTION OF THE KIT D816V MUTATION IN PATIENTS WITH SUSPECTED SYSTEMIC MASTOCYTOSIS
    Martelli, M.
    Bavaro, L.
    De Matteis, G.
    Rondoni, M.
    Zanotti, R.
    Bonifacio, M.
    Papayannidis, C.
    Curti, A.
    Monaldi, C.
    De Santis, S.
    Mancini, M.
    Cavo, M.
    Soverini, S.
    HAEMATOLOGICA, 2019, 104 : 106 - 106
  • [48] Utility of Peripheral Blood KIT D816V Mutation Detection Droplet Digital Polymerase Chain Reaction Testing
    Mannion, Peter
    Nakashima, Megan
    LABORATORY INVESTIGATION, 2025, 105 (03)
  • [49] Highly Aggressive de novo Aleukemic Variant of Mast Cell Leukemia Without KIT D816V Mutation
    Suh, Myung Chul
    Ham, Ji Yeon
    Park, Tae-In
    Moon, Joon Ho
    Suh, Jang Soo
    ANNALS OF LABORATORY MEDICINE, 2017, 37 (06) : 547 - 549
  • [50] High frequency of concomitant mastocytosis in patients with acute myeloid leukemia exhibiting the transforming KIT mutation D816V
    Fritsche-Polanz, Robert
    Fritz, Marika
    Huber, Andrea
    Sotlar, Karl
    Sperr, Wolfgang R.
    Mannhalter, Christine
    Foedinger, Manuela
    Valent, Peter
    MOLECULAR ONCOLOGY, 2010, 4 (04) : 335 - 346
12345